Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO) Insider Trading Activity – Major Shareholder Sold 117,140 shares of Stock

Insider Trading Activity For Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)

Story continues below

Bioventures Ltd Novartis , Major Shareholder of Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO) reportedly Sold 117,140 shares of the company’s stock at an average price of 1.05 for a total transaction amount of $122,997.00 SEC Form

Insider Trading History For Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)

  • On 3/20/2018 Muneer A Satter, Director, bought 13,000 with an average share price of $4.97 per share and the total transaction amounting to $64,610.00.
  • On 3/23/2018 Muneer A Satter, Director, bought 5,000 with an average share price of $4.88 per share and the total transaction amounting to $24,400.00.
  • On 6/28/2018 Muneer A Satter, Director, bought 1,818,182 with an average share price of $3.85 per share and the total transaction amounting to $7,000,000.70.
  • On 8/20/2018 Bioventures Ltd Novartis, Major Shareholder, sold 5,300 with an average share price of $3.90 per share and the total transaction amounting to $20,670.00.
  • On 11/12/2018 Stephen J Hoffman, CEO, bought 31,967 with an average share price of $2.01 per share and the total transaction amounting to $64,253.67.
  • On 11/30/2018 Muneer A Satter, Director, bought 60,000 with an average share price of $1.98 per share and the total transaction amounting to $118,800.00.
  • On 12/6/2018 Muneer A Satter, Director, bought 60,000 with an average share price of $2.09 per share and the total transaction amounting to $125,400.00.
  • Analyst Ratings History For Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)

    Recent Trading Activity for Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)
    Shares of Aerpio Pharmaceuticals Inc closed the previous trading session at with 26741 shares trading hands.

    An ad to help with our costs